Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae

Journal of Veterinary Medicine, Series B

Volumn 49, Issue 10, 2002, Pages 513-518

  Tanigawa, M ^a   Sawada, T ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; PENICILLIN DERIVATIVE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; CHEMISTRY; DRUG EFFECT; GERMFREE ANIMAL; INTRAMUSCULAR DRUG ADMINISTRATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PNEUMONIA; SWINE; SWINE DISEASE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; AMOXICILLIN; ANIMALS; CHEMISTRY, PHARMACEUTICAL; INJECTIONS, INTRAMUSCULAR; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PLEUROPNEUMONIA; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); SUIDAE; SUS SCROFA;

EID: 0036936027     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0450.2002.00604.x     Document Type: Article

References (26)

1. Agerso, H., and C. Friis, 1998: Penetration of amoxycillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoiae infected pigs. Res. Vet. Sci. 64, 251-257.
2. Craig, W. A., and S. C. Ebert, 1992: Continuous infusion of β-lactam antibiotics. Antimicrob. Agent Chemother. 36, 2577-2583.
3. Committee for determination method, 1981; Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy (Tokyo) 29, 76-79.
4. Drusano, G. L., 1988: Role of pharmacokinetics in the outcome of infection. Antimicrob. Agent Chemother. 32, 289-297.
5. Farzam, F., and B. J. Plotkin, 2001: Effects of sub-MICs of antibiotics on the hydrophobicity and production of acidic polysaccharide by Vibrio vulnificus. Chemotherapy 47, 184-193.
6. Fedorka-Cray, P. J., W. C., Cray Jr, J. T., Gray, S. A., Breisch, L., Hoffman, G. A., Anderson 1993: Actinobacillus (Haemophilus) pleuropneumoniae. Part 1. History, epidemiology, serotyping, and treatment. Comp. Cont. Edu. Pract. Vet. 15, 1447-1455.
7. Fenwick, B., and S. Henry 1994: Porcine pleuropneumonia. J. Am. Vet. Med. Assoc. 204, 1334-1340.
8. Friis, C., 2000: Role of pharmacokinetics and pharmacodynamics in the outcome of infection. Proc. Int. Pig. Vet. Soc. Congr. 16, 82-84.
9. Kondo, F., and S. Satoh, 1995: Effects of subminimal inhibitory concentrations of β-lactam antibiotics against R-plasmid-bearing bacteria. Chemotherapy 41, 125-133.
10. Kondo, F., and H. Kuroki, 2001: The effects of subminimal inhibitory concentrations of β-lactam antibiotics against Clostridium perfrigens. Microbios 105, 163-174.
11. Kundrat, W., 1972: Quick 45-Minute method for the microbiological detection of inhibitors in animal products. Die Fleischwirtschaft 4, 485-487.
12. Kunin, C. M., 1981: Dosage schedules of antimicrobial agents: a historical review. Rev. Infect. Dis. 3, 4-11.
13. Lee, S. Y., 2000: Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on Streptococcus gordonii and Streptococcus sanguis. J. Chemother. 12, 379-384.
14. Lidecrona, R. H., C. Friis, and N. E. Jensen, 1999: The pharmacodynamic effect of amoxicillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model. Res. Vet. Sci. 67, 93-97.
15. Lorian, V., 1985: Low concentaration of antibiotics. J. Antimicrob. Chemother. 15(Suppl. A), 15-26.
16. Lorian, V., 1993: Medical relevance of low concentration of antibodies. J. Antimicrob. Chemother. 31(Suppl. D), 137-148.
17. Odenholt-Tornovist, I., S. E. Holm, and O. Cars, 1990: Effects of supra- and sub-MIC benzylpenicillin concentrations on group A β-haemolytic streptococci during the postantibiotic phase in vivo. J. Antimicrob. Chemother. 26, 193-201.
18. Odenholt, I., 2001: Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int. J. Antimicrob. Agents 17, 1-8.
19. Ono, Y., Y. Ueda, M. Baba, H. Nishiya, and O. Kunii, 1989: Influence of a sub-inhibitory concentration of antibiotics on opsono-phagocytic functions of Klebsiella pneumoniae by human phagocytes. Chemotherapy (Tokyo) 37, 1487-1491.
20. Raponi, G., N. Keller, B. P. Overbeek, M. Rozenberg-Arska, K. P. M. Van Kessel, and J. Verhoef, 1990: Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MIC of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob. Agent Chemother. 34, 332-336.
21. Roosendaal, R., I. A. J. M. Bakker-Wouderberg, M. Van-Den Berghe-Van Raffe, and M. F. Michel, 1986. Continuous versus inetrmittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob. Agent Chemother. 30, 403-408.
22. Soriano, F., 1992: Optimal dosage of β-lactam antibiotics: time above the MIC and inoculum effect. J. Antimicrob. Chemother. 30, 566-569.
23. Vogelman, B. S., and W. A. Craig, 1985: Postantibiotic effects. J. Antimicrob. Chemother. 15(Suppl. A), 37-46.
24. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988: Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158, 831-847.
25. White, C. A., and R. D. Toothaker, 1985: Influence of ampicillin elimination half-life on in-vitro bactericidal effect. J. Antimicrob. Chemother. 15 (Suppl. A.), 257-260.
26. Zinner, S. H., M. N. Dudley, D. Gilbert, and M. Bassignani, 1988: Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host. Am. J. Med. 85(Suppl. 1A), 56-58.